News
-
-
-
PRESS RELEASE
Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program
Onco-Innovations partners with Nanosoft Polymers for polymer process and drug formulation optimization activities. Appointment of Dave Antony as VP Corporate Finance announced -
-
-
PRESS RELEASE
Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program
Onco-Innovations successfully scales kilogram manufacturing for ONC010 B4 precursor component, advancing nanoparticle-formulated PNKP Inhibitor Technology. Engages InvestorBrandNetwork (IBN) for market services -
-
-
PRESS RELEASE
Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program
Onco-Innovations Limited reports progress in scale-up and development for ONC010 oncology program, focusing on A83 and B4 precursor components. Collaboration with Dalton Pharma Services aims at future GMP production -
